Associated Papers
Benefits for children with suspected cancer from routine whole-genome sequencing.
Hodder A et al.
Nature Medicine, 2024
Genomic ALK alterations in primary and relapsed neuroblastoma.
Rosswog C et al.
British Journal of Cancer, 2023
36807339 (PubMed )
Supplement: 41416_2023_2208_MOESM1_ESM.pdf
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment.
Lambertz I et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2015
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.
Schulte JH et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2011
Select a paper to view details